JimJimJimJim Posted July 25, 2014 Share Posted July 25, 2014 Our special guest speaker today, endocrinologist Dr Jane Holmes-Walker), told us that Xgeva (denosumab) is being more used today than Zometa (zoledronic acid) to prevent skeletal events (broken bones, or compressed spine bones) in metastatic prostate cancer. We published a key study on this back in September 2012. If you wish to see that study again, click on this sentence. OR http://forums.jimjimjimjim.com/index.php?/topic/534-denosumab-or-zometa-for-protection-of-bones-in-prostate-cancer/ Link to comment Share on other sites More sharing options...
This topic is now archived and is closed to further replies.